Melanocytic nevus pathophysiology: Difference between revisions
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
*BRAF V600E mutations have a very high corelation with small congenital melanocytic nevi (CMN), acquired melanocytic nevi and cutaneous melanomas.<ref name="pmid16691193">{{cite journal |vauthors=Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, Fujimoto A, Hatta N, Saida T |title=High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi |journal=J. Invest. Dermatol. |volume=126 |issue=9 |pages=2111–8 |date=September 2006 |pmid=16691193 |doi=10.1038/sj.jid.5700366 |url=}}</ref><ref name="pmid18032947">{{cite journal |vauthors=Wu J, Rosenbaum E, Begum S, Westra WH |title=Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis |journal=Am J Dermatopathol |volume=29 |issue=6 |pages=534–7 |date=December 2007 |pmid=18032947 |doi=10.1097/DAD.0b013e3181584950 |url=}}</ref> | *BRAF V600E mutations have a very high corelation with small congenital melanocytic nevi (CMN), acquired melanocytic nevi and cutaneous melanomas.<ref name="pmid16691193">{{cite journal |vauthors=Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, Fujimoto A, Hatta N, Saida T |title=High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi |journal=J. Invest. Dermatol. |volume=126 |issue=9 |pages=2111–8 |date=September 2006 |pmid=16691193 |doi=10.1038/sj.jid.5700366 |url=}}</ref><ref name="pmid18032947">{{cite journal |vauthors=Wu J, Rosenbaum E, Begum S, Westra WH |title=Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis |journal=Am J Dermatopathol |volume=29 |issue=6 |pages=534–7 |date=December 2007 |pmid=18032947 |doi=10.1097/DAD.0b013e3181584950 |url=}}</ref> | ||
*While giant congenital melanocytic nevi (CMN) have somatic gain-of-function mutations in NRAS.<ref name="pmid18633438">{{cite journal |vauthors=Dessars B, De Raeve LE, Morandini R, Lefort A, El Housni H, Ghanem GE, Van den Eynde BJ, Ma W, Roseeuw D, Vassart G, Libert F, Heimann P |title=Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis |journal=J. Invest. Dermatol. |volume=129 |issue=1 |pages=139–47 |date=January 2009 |pmid=18633438 |doi=10.1038/jid.2008.203 |url=}}</ref><ref name="pmid24129063">{{cite journal |vauthors=Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, How-Kit A, Su X, Coulomb-L'Hermine A, Tost J, Mourah S, Aractingi S, Guégan S |title=NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi |journal=J. Invest. Dermatol. |volume=134 |issue=4 |pages=1067–1074 |date=April 2014 |pmid=24129063 |doi=10.1038/jid.2013.429 |url=}}</ref> | *While giant congenital melanocytic nevi (CMN) have somatic gain-of-function mutations in NRAS.<ref name="pmid18633438">{{cite journal |vauthors=Dessars B, De Raeve LE, Morandini R, Lefort A, El Housni H, Ghanem GE, Van den Eynde BJ, Ma W, Roseeuw D, Vassart G, Libert F, Heimann P |title=Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis |journal=J. Invest. Dermatol. |volume=129 |issue=1 |pages=139–47 |date=January 2009 |pmid=18633438 |doi=10.1038/jid.2008.203 |url=}}</ref><ref name="pmid24129063">{{cite journal |vauthors=Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, How-Kit A, Su X, Coulomb-L'Hermine A, Tost J, Mourah S, Aractingi S, Guégan S |title=NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi |journal=J. Invest. Dermatol. |volume=134 |issue=4 |pages=1067–1074 |date=April 2014 |pmid=24129063 |doi=10.1038/jid.2013.429 |url=}}</ref> | ||
*Compared to acquired melanocytic nevi, CMN penetrate into deeper layers of dermis.<ref name="pmid4756859">{{cite journal |vauthors=Mark GJ, Mihm MC, Liteplo MG, Reed RJ, Clark WH |title=Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies |journal=Hum. Pathol. |volume=4 |issue=3 |pages=395–418 |date=September 1973 |pmid=4756859 |doi= |url=}}</ref> | |||
===Gross Pathology=== | ===Gross Pathology=== | ||
Revision as of 16:17, 15 May 2019
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Melanocytic nevus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanocytic nevus pathophysiology On the Web |
|
American Roentgen Ray Society Images of Melanocytic nevus pathophysiology |
|
Risk calculators and risk factors for Melanocytic nevus pathophysiology |
Editors-In-Chief: Martin I. Newman, M.D., FACS, Cleveland Clinic Florida, [1];Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2] Michel C. Samson, M.D., FRCSC, FACS [3]
Overview
Melanocytic nevus is a benign growth on the skin (usually tan, brown, or flesh-colored) that contains a cluster of melanocytes and surrounding supportive tissue.
Pathophysiology
Congenital melanocytic nevi (CMN)
- Congenital melanocytic nevi (CMN) are hamartomas lesions.
- During embryogenesis clonal proliferations of benign melanocytes may give rise to melanocytic nevi.[1][2]
- BRAF V600E mutations have a very high corelation with small congenital melanocytic nevi (CMN), acquired melanocytic nevi and cutaneous melanomas.[3][4]
- While giant congenital melanocytic nevi (CMN) have somatic gain-of-function mutations in NRAS.[5][6]
- Compared to acquired melanocytic nevi, CMN penetrate into deeper layers of dermis.[7]
Gross Pathology
.jpg)
References
- ↑ Tannous ZS, Mihm MC, Sober AJ, Duncan LM (February 2005). "Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management". J. Am. Acad. Dermatol. 52 (2): 197–203. doi:10.1016/j.jaad.2004.07.020. PMID 15692463.
- ↑ Price HN, Schaffer JV (2010). "Congenital melanocytic nevi-when to worry and how to treat: Facts and controversies". Clin. Dermatol. 28 (3): 293–302. doi:10.1016/j.clindermatol.2010.04.004. PMID 20541682.
- ↑ Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, Fujimoto A, Hatta N, Saida T (September 2006). "High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi". J. Invest. Dermatol. 126 (9): 2111–8. doi:10.1038/sj.jid.5700366. PMID 16691193.
- ↑ Wu J, Rosenbaum E, Begum S, Westra WH (December 2007). "Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis". Am J Dermatopathol. 29 (6): 534–7. doi:10.1097/DAD.0b013e3181584950. PMID 18032947.
- ↑ Dessars B, De Raeve LE, Morandini R, Lefort A, El Housni H, Ghanem GE, Van den Eynde BJ, Ma W, Roseeuw D, Vassart G, Libert F, Heimann P (January 2009). "Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis". J. Invest. Dermatol. 129 (1): 139–47. doi:10.1038/jid.2008.203. PMID 18633438.
- ↑ Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, How-Kit A, Su X, Coulomb-L'Hermine A, Tost J, Mourah S, Aractingi S, Guégan S (April 2014). "NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi". J. Invest. Dermatol. 134 (4): 1067–1074. doi:10.1038/jid.2013.429. PMID 24129063.
- ↑ Mark GJ, Mihm MC, Liteplo MG, Reed RJ, Clark WH (September 1973). "Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies". Hum. Pathol. 4 (3): 395–418. PMID 4756859.